Lista de obras -

A randomized controlled trial of the effect of spironolactone on left ventricular mass in hemodialysis patients

artículo científico publicado en 2019

Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients

artículo científico publicado en 2012

Antibodies to platelet factor 4-heparin complex and outcome in hemodialysis patients with diabetes

artículo científico publicado en 2010

Apolipoprotein E genotype predicts cardiovascular endpoints in dialysis patients with type 2 diabetes mellitus

artículo científico publicado en 2009

Are glucokinase mutations associated with low triglycerides?

artículo científico publicado en 2005

Association Between Dietary Patterns and Kidney Function in Patients With Chronic Kidney Disease: A Cross-Sectional Analysis of the German Chronic Kidney Disease Study

scientific article published on 21 November 2019

Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus

artículo científico publicado en 2009

Association of Serum Uromodulin with Death, Cardiovascular Events, and Kidney Failure in CKD

scientific article published on 14 April 2020

Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD.

artículo científico publicado en 2011

At which stage of chronic kidney disease should dyslipidemia be treated?

artículo científico publicado en 2006

Atorvastatin and Low-Density Lipoprotein Cholesterol in Type 2 Diabetes Mellitus Patients on Hemodialysis ⬇️

artículo científico publicado el 14 de abril de 2011

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

artículo científico publicado en 2005

C-reactive protein and uremia

scientific article published on July 2009

Cardiovascular Outcomes Reported in Hemodialysis Trials

artículo científico publicado en 2018

Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients

artículo científico publicado en 2008

Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients

Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction, and mortality in hemodialysis patients

artículo científico publicado en 2009

Copeptin Associates with Cause-Specific Mortality in Patients with Impaired Renal Function: Results from the LURIC and the 4D Study

artículo científico publicado en 2017

Copeptin Levels Associate with Cardiovascular Events in Patients with ESRD and Type 2 Diabetes Mellitus ⬇️

artículo científico publicado el 17 de marzo de 2011

Correction: Heart Failure in a Cohort of Patients with Chronic Kidney Disease: The GCKD Study

artículo científico publicado en 2015

Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis

scientific article published on 01 February 2007

Dyslipidemia, inflammation and dialysis outcomes: what we know now.

artículo científico publicado en 2006

Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysis

artículo científico publicado en 2008

Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials

scientific article published on 16 March 2011

Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials

artículo científico publicado en 2012

Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis

artículo científico publicado en 2009

Establishing Core Cardiovascular Outcome Measures for Trials in Hemodialysis: Report of an International Consensus Workshop

artículo científico publicado en 2020

Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies

artículo científico publicado en 2015

Genome-wide association study identifies 3 genomic loci significantly associated with serum levels of homoarginine: the AtheroRemo Consortium.

artículo científico publicado en 2013

Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease - cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort

artículo científico publicado en 2016

Glycemic control and cardiovascular events in diabetic hemodialysis patients

artículo científico

HDL Cholesterol Efflux Does Not Predict Cardiovascular Risk in Hemodialysis Patients

artículo científico publicado en 2016

HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients

artículo científico publicado en 2014

Heart failure in a cohort of patients with chronic kidney disease: the GCKD study

artículo científico publicado en 2015

Hidden population substructures in an apparently homogeneous population bias association studies

artículo científico publicado en 2006

Homoarginine, cardiovascular risk, and mortality

artículo científico publicado en 2010

Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients

artículo científico publicado en 2011

Homoarginine, kidney function and cardiovascular mortality risk

artículo científico publicado en 2014

Identifying critically important cardiovascular outcomes for trials in hemodialysis: an international survey with patients, caregivers and health professionals

artículo científico publicado en 2020

Impact of vitamin A on clinical outcomes in haemodialysis patients

artículo científico publicado en 2011

Implementation of the KDIGO guideline on lipid management requires a substantial increase in statin prescription rates

artículo científico publicado en 2015

Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop

article by Allison Tong et al published December 2018 in Kidney International

Intestinal cholesterol absorption, treatment with atorvastatin, and cardiovascular risk in hemodialysis patients

artículo científico publicado en 2015

Lipid metabolism in chronic kidney disease: the role of statins in cardiovascular risk

artículo científico publicado en 2007

Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study.

artículo científico publicado en 2016

Lipoprotein‐associated phospholipase A2 and outcome in patients with type 2 diabetes on haemodialysis ⬇️

artículo científico publicado el 29 de diciembre de 2011

Long-Term Survivor Characteristics in Hemodialysis Patients with Type 2 Diabetes

artículo científico publicado en 2018

Long-term effects following 4 years of randomized treatment with atorvastatin in patients with type 2 diabetes mellitus on hemodialysis

artículo científico publicado en 2016

Low homoarginine concentration is a novel risk factor for heart disease

artículo científico publicado en 2011

Low plasma α-tocopherol concentrations and adverse clinical outcomes in diabetic hemodialysis patients

artículo científico publicado en 2013

Low serum homoarginine is a novel risk factor for fatal strokes in patients undergoing coronary angiography

artículo científico publicado en 2011

Mitochondrial DNA copy number is associated with mortality and infections in a large cohort of patients with chronic kidney disease

scientific article published on 10 May 2019

Non-high-density lipoprotein cholesterol: a target of lipid-lowering in dialysis patients

artículo científico publicado en 2003

Pregnancy-associated plasma protein A associates with cardiovascular events in diabetic hemodialysis patients

artículo científico publicado en 2014

Prognostic Value of High-Sensitivity Versus Conventional Cardiac Troponin T Assays Among Patients With Type 2 Diabetes Mellitus Undergoing Maintenance Hemodialysis

artículo científico publicado en 2018

Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis.

artículo científico publicado en 2014

Quantification of left ventricular mass by echocardiography compared to cardiac magnet resonance imaging in hemodialysis patients

scientific article published on 16 September 2020

Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics

artículo científico publicado en 2004

Rationale and design of the Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease Study (MiREnDa).

artículo científico publicado en 2013

Recent Advances in the Treatment of Atherogenic Dyslipidemia in Type 2 Diabetes Mellitus ⬇️

artículo científico publicado el 21 de junio de 2011

Risk factors for retinopathy in hemodialysis patients with type 2 diabetes mellitus

artículo científico publicado en 2020

Sample sizes for clinical trials with time-to-event endpoints and competing risks

artículo científico publicado en 2005

Should we aim for oral health to improve outcomes in chronic kidney disease?

artículo científico publicado en 2016

Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)

artículo científico publicado en 2016

Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.

artículo científico publicado en 2017

Statins and aspirin in chronic kidney disease: what does the UK-HARP-I trial tell us?

artículo científico publicado en 2005

Statins, inflammation and kidney disease ⬇️

artículo científico publicado el 31 de mayo de 2011

Status of periodontal health in German patients suffering from chronic kidney disease-Data from the GCKD study

artículo científico publicado en 2019

Study design of DIACORE (DIAbetes COhoRtE) – a cohort study of patients with diabetes mellitus type 2 ⬇️

artículo científico publicado el 14 de febrero de 2013

Sunrise of Statins after AURORA and 4D? ⬇️

artículo científico publicado el 16 de junio de 2011

The German Chronic Kidney Disease (GCKD) study: design and methods

artículo científico publicado en 2011

The association between parathyroid hormone and mortality in dialysis patients is modified by wasting

artículo científico publicado en 2009

The effect of high-flux hemodialysis on hemoglobin concentrations in patients with CKD: results of the MINOXIS study

artículo científico publicado en 2011

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

artículo científico publicado en 2011

The metabolic burden of diabetes and dyslipidaemia in chronic kidney disease

artículo científico publicado en 2002

Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients

artículo científico publicado en 2013

Transthyretin predicts cardiovascular outcome in hemodialysis patients with type 2 diabetes

artículo científico publicado en 2012

Uremia-specific alterations in lipid metabolism

artículo científico publicado en 2002

Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients

artículo científico publicado en 2010

Wasting and Sudden Cardiac Death in Hemodialysis Patients: A Post Hoc Analysis of 4D (Die Deutsche Diabetes Dialyse Studie)

scientific article published on 05 August 2011

Lista de obras de

A randomized controlled trial of the effect of spironolactone on left ventricular mass in hemodialysis patients

Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients

Antibodies to platelet factor 4-heparin complex and outcome in hemodialysis patients with diabetes

Apolipoprotein E genotype predicts cardiovascular endpoints in dialysis patients with type 2 diabetes mellitus

Are glucokinase mutations associated with low triglycerides?

Association Between Dietary Patterns and Kidney Function in Patients With Chronic Kidney Disease: A Cross-Sectional Analysis of the German Chronic Kidney Disease Study

Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus

Association of Serum Uromodulin with Death, Cardiovascular Events, and Kidney Failure in CKD

Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD.

At which stage of chronic kidney disease should dyslipidemia be treated?

Atorvastatin and Low-Density Lipoprotein Cholesterol in Type 2 Diabetes Mellitus Patients on Hemodialysis ⬇️

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

C-reactive protein and uremia

Cardiovascular Outcomes Reported in Hemodialysis Trials

Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients

Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients

Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction, and mortality in hemodialysis patients

Copeptin Associates with Cause-Specific Mortality in Patients with Impaired Renal Function: Results from the LURIC and the 4D Study

Copeptin Levels Associate with Cardiovascular Events in Patients with ESRD and Type 2 Diabetes Mellitus ⬇️

Correction: Heart Failure in a Cohort of Patients with Chronic Kidney Disease: The GCKD Study

Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis

Dyslipidemia, inflammation and dialysis outcomes: what we know now.

Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysis

Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials

Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials

Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis

Establishing Core Cardiovascular Outcome Measures for Trials in Hemodialysis: Report of an International Consensus Workshop

Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies

Genome-wide association study identifies 3 genomic loci significantly associated with serum levels of homoarginine: the AtheroRemo Consortium.

Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease - cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort

Glycemic control and cardiovascular events in diabetic hemodialysis patients

HDL Cholesterol Efflux Does Not Predict Cardiovascular Risk in Hemodialysis Patients

HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients

Heart failure in a cohort of patients with chronic kidney disease: the GCKD study

Hidden population substructures in an apparently homogeneous population bias association studies

Homoarginine, cardiovascular risk, and mortality

Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients

Homoarginine, kidney function and cardiovascular mortality risk

Identifying critically important cardiovascular outcomes for trials in hemodialysis: an international survey with patients, caregivers and health professionals

Impact of vitamin A on clinical outcomes in haemodialysis patients

Implementation of the KDIGO guideline on lipid management requires a substantial increase in statin prescription rates

Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop

Intestinal cholesterol absorption, treatment with atorvastatin, and cardiovascular risk in hemodialysis patients

Lipid metabolism in chronic kidney disease: the role of statins in cardiovascular risk

Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study.

Lipoprotein‐associated phospholipase A2 and outcome in patients with type 2 diabetes on haemodialysis ⬇️

Long-Term Survivor Characteristics in Hemodialysis Patients with Type 2 Diabetes

Long-term effects following 4 years of randomized treatment with atorvastatin in patients with type 2 diabetes mellitus on hemodialysis

Low homoarginine concentration is a novel risk factor for heart disease

Low plasma α-tocopherol concentrations and adverse clinical outcomes in diabetic hemodialysis patients

Low serum homoarginine is a novel risk factor for fatal strokes in patients undergoing coronary angiography

Mitochondrial DNA copy number is associated with mortality and infections in a large cohort of patients with chronic kidney disease

Non-high-density lipoprotein cholesterol: a target of lipid-lowering in dialysis patients

Pregnancy-associated plasma protein A associates with cardiovascular events in diabetic hemodialysis patients

Prognostic Value of High-Sensitivity Versus Conventional Cardiac Troponin T Assays Among Patients With Type 2 Diabetes Mellitus Undergoing Maintenance Hemodialysis

Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis.

Quantification of left ventricular mass by echocardiography compared to cardiac magnet resonance imaging in hemodialysis patients

Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics

Rationale and design of the Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease Study (MiREnDa).

Recent Advances in the Treatment of Atherogenic Dyslipidemia in Type 2 Diabetes Mellitus ⬇️

Risk factors for retinopathy in hemodialysis patients with type 2 diabetes mellitus

Sample sizes for clinical trials with time-to-event endpoints and competing risks

Should we aim for oral health to improve outcomes in chronic kidney disease?

Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)

Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.

Statins and aspirin in chronic kidney disease: what does the UK-HARP-I trial tell us?

Statins, inflammation and kidney disease ⬇️

Status of periodontal health in German patients suffering from chronic kidney disease-Data from the GCKD study

Study design of DIACORE (DIAbetes COhoRtE) – a cohort study of patients with diabetes mellitus type 2 ⬇️

Sunrise of Statins after AURORA and 4D? ⬇️

The German Chronic Kidney Disease (GCKD) study: design and methods

The association between parathyroid hormone and mortality in dialysis patients is modified by wasting

The effect of high-flux hemodialysis on hemoglobin concentrations in patients with CKD: results of the MINOXIS study

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

The metabolic burden of diabetes and dyslipidaemia in chronic kidney disease

Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients

Transthyretin predicts cardiovascular outcome in hemodialysis patients with type 2 diabetes

Uremia-specific alterations in lipid metabolism

Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients